Guidelines for practical use of MAL-PDT in non-melanoma skin cancer: REVIEW ARTICLE

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 5, 2010, Pages 505-512

  Christensen, E ^a   Warloe, T ^b   Kroon, S ^c   Funk, J ^d   Helsing, P ^b   Soler, Am ^b   Stang, Hj ^e   Vatne, Ø ^f   Mork C ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d Dr Funks Hudklinikk ^*  (Norway)

^e Holdbergsplads Legesenter   (Norway)

^f Central Hospital   (Norway)

Author keywords

Aminolaevulinic acid; Guidelines; Methyl aminolaevulinic acid; Non melanoma skin cancer; Procedural PDT; Topical photodynamic therapy

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALBYL E; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BUPIVACAINE; CAPSAICIN; CLOPIDOGREL; EMLA; LIDOCAINE; MEPIVACAINE; MORPHINE; PARACETAMOL; SALICYLIC ACID; TETRACAINE; TICLOPIDINE; UNCLASSIFIED DRUG; UREA; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; APPLICATION SITE PAIN; BASAL CELL CARCINOMA; BOWEN DISEASE; CLINICAL EXAMINATION; CLINICAL PRACTICE; COMPRESSION BANDAGE; COMPRESSION THERAPY; DIATHERMY; ESTHETICS; FATIGUE; FOLLOW UP; HEADACHE; HUMAN; INDIVIDUALIZATION; INTERNATIONAL NORMALIZED RATIO; KERATOSIS; LIGHT EMITTING DIODE; MEDICAL LITERATURE; MEDICAL SPECIALIST; NAUSEA; NORWAY; PARESTHESIA; PATIENT INFORMATION; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SKIN BLEEDING; SKIN CANCER; SKIN MANIFESTATION; SUTURING METHOD; TREATMENT INDICATION; TREATMENT OUTCOME; WOUND CARE; ANALOGS AND DERIVATIVES; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

AMINOLEVULINIC ACID; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRACTICE GUIDELINES AS TOPIC; SKIN NEOPLASMS;

EID: 77950823898     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03430.x     Document Type: Review

References (57)

1. Peng Q, Warloe T, Berg K et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997 79 : 2282 2308. (Pubitemid 27251011)
2. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990 6 : 143 148.
3. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 2001 62 : 140 145. (Pubitemid 32898834)
4. Sandberg C, Halldin CB, Ericson MB, Larkö O, Krogstad AL, Wennberg AM. Bioavaiability of aminolaevuliniv acid and methylaminolaevulinate in basal cell carcinoma: a perfusion study using microdialysis in vivo. Br J Dermatol 2008 159 : 1170 1176.
5. Calvzavara-Pinton PG, Venturini M, Sala R. Photodynamic therapy: update 2006 part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol 2007 21 : 293 302. (Pubitemid 46243319)
6. Braathen LR, Szeimies RM, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007 56 : 125 143.
7. Morton C, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008 159 : 1245 1266.
8. Horn M, Wolf P, Wulf HC et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003 149 : 1242 1249. (Pubitemid 38058101)
9. Rubino C, Soggiu D, Farace F, Lissia M, Alfano C, Campus GV. Treatment of non-melanoma skin cancer in North Sardinia: is there a need for biopsy? Acta Chir Plast 2004 46 : 110 114. (Pubitemid 40109690)
10. Vinciullo C, Elliott T, Francis D et al. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 2005 152 : 765 772. (Pubitemid 40571312)
11. Kuijpers DI, Thissen MR, Neumann MH. Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol 2002 3 : 247 259.
12. de Visscher JG, Schaapveld M, Grond AJ, van de Waal I. Relationship of tumor thickness in punch biopsy and subsequent surgical specimens in stage I squamous cell carcinoma of the lower lip. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 88 : 141 144.
13. Derrich EK, Smith R, Mercher DH, Morrison EA, Kirham N, Darley CR. The use of cytology in the diagnosis of basal cell carcinoma. Br J Dermatol 1994 130 : 561 563. (Pubitemid 24204689)
14. Berner AA, Soler A, Warloe T. Skin scrape cytology in diagnosis of nodular basal cell carcinoma for treatment by photodynamic therapy. Acta Derm Venereol 1999 79 : 149 149. (Pubitemid 29185313)
15. Christensen E, Bofin A, Gudmundsdottir I, Skogvoll E. Cytological diagnosis of basal cell carcinoma and actinic keratosis using Papanicolaou and May-Grünwald-Giemsa stained cutaneous tissue smear. Cytopathology 2008 19 : 316 322.
16. Gerritsen MJ, Smits T, Kleinpenning MM, van de Kerkhof PC, van Erp PE. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 2009 218 : 193 202.
17. Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 2005 85 : 424 428. (Pubitemid 41345617)
18. Dragieva G, Prinz BM, Hafner J et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis in transplant recipients. Br J Dermatol 2004 151 : 196 200. (Pubitemid 39061299)
19. Haller JC, Cairnduff F, Slack G et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000 143 : 1270 1274. (Pubitemid 32052766)
20. Ratner D, Bagiella E. The efficacy of curretage in delineating margins of basal cell carcinoma before Mohs micrographic surgery. Dermatol Surg 2003 29 : 899 903. (Pubitemid 37087444)
21. Warloe T, Peng Q, Heyerdahl H, Moan J, Steen HB, Gigcksky K-E. Photodynamic therapy with 5-aminolaevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. SPIE 1994 2371 : 226 235.
22. Moseley H, Brancaleon L, Lesar AE, Ferguson J, Ibbotson SH. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo? Photodermatol Photoimmunol Photomed 2008 24 : 72 75. (Pubitemid 351436827)
23. Burg G, Hirsch RD, Konz B, Braun-Falco O. Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermatol Surg 1975 1 : 21 24. (Pubitemid 8107977)
24. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinoma using a prior debulking technique. Br J Dermatol 2000 142 : 338 339.
25. Lademann J, Ilgevicius A, Zurbau O et al. Penetration studies of topically applied substances: optical determination of the amount of stratum corneum removed by tape stripping. J Biomed Opt 2006 11 : 1-6, 054026. (Pubitemid 44883910)
26. Donnelly RF, Morrow DI, McCarron PA et al. Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochem Photobiol 2009 85 : 195 204.
27. Basset-Seguin N, Ibbotson SH, Emtestam L et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008 18 : 547 553.
28. Juzeniene A, Juzenas P, Kaalhus O, Iani V, Moan J. Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin. Photochem Photobiol 2002 76 : 452 456.
29. Monfrecola M, Procaccini EM, D'Onofrio D et al. Hyperpigmentation induced by topical 5-aminolaevulinic acid plus visible light. J Photochem Photobiol B 2002 68 : 147 155. (Pubitemid 35469834)
30. Lehmann P. Side effects of topical photodynamic therapy. Hautarzt 2007 58 : 597 603. (Pubitemid 47087492)
31. Rhodes LE, De Rie M, Enstrom Y et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004 140 : 17 23. (Pubitemid 38090266)
32. Yokoyama S, Nakano H, Nishizawa A, Kaneko T, Harada K, Hanada K. A case of photocontact urticaria induced by photodynamic therapy with topical 5-aminolaevulinic acid. J Dermatol 2005 32 : 843 847. (Pubitemid 41703765)
33. Hohwy T, Andersen KE, Solvsten H, Sommerlund M. Allergic contact dermatitis to methyl aminolevulinate after photodynamic therapy in 9 patients. Contact Dermatitis 2007 57 : 321 323. (Pubitemid 47568796)
34. Lee CF, Lee CJ, Chen CT, Huang CT. delta-Aminolaevulinic acid mediated photodynamic antimicrobial chemotherapy on Pseudomonas aeruginosa planktonic and biofilm cultures. J Photochem Photobiol B 2004 19 : 21 25.
35. Zeina B, Greenman J, Corry D, Purcell WM. Antimicrobial photodynamic therapy: assessment of genotoxic effects on keratinocytes in vitro. Br J Dermatol 2003 148 : 229 232. (Pubitemid 36278961)
36. Lindeburg KE, Brogaard HM, Jemec GB. Pain and photodynamic therapy. Dermatology 2007 215 : 206 208.
37. Grappengiesser S, Gudmundsson F, Larko O et al. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002 27 : 493 497. (Pubitemid 35278943)
38. Sandberg C, Stenquist B, Rosdahl I et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006 86 : 404 408. (Pubitemid 44450094)
39. Wennberg AM. Pain, pain relief and other practical issues in photodynamic therapy. Australas J Dermatol 2005 46 (Suppl. 3 S3 S4.
40. Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006 5 : 353 356.
41. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007 157 : 87 91. (Pubitemid 46934264)
42. Kapur N, Kernland K, Braathen LR. Photodynamic therapy-induced pain: a patient centred survey. J Am Acad Dermatol 2004 50 : issue 3.
43. Paoli J, Halldin C, Ericson MB, Wennberg AM. Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol 2008 33 : 559 564. (Pubitemid 351743894)
44. Halldin CB, Paoli J, Sandberg C, Gonzalez H, Wennberg AM. Nerve blocks enable adequate relief during topical photodynamic therapy of field cancerization on the forehead and scalp. Br J Dermatol 2009 160 : 795 800.
45. Nielsen KP, Juzeniene A, Juzenas P, Stamnes K, Stamnes JJ, Moan J. Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem Photobiol 2005 81 : 1190 1194. (Pubitemid 41545945)
46. Holmes MV, Dawe RS, Fergusen J, Ibbotson SH. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 2004 150 : 337 340.
47. Skiveren J, Haedersdal M, Philipsen PA, Wiegell SR, Wulf HC. Morphine Gel 0,3% does not relieve pain during topical photodynamic therapy; A randomized, double-blind, placebocontrolled study. Acta Derm Venereol 2006 86 : 409 411. (Pubitemid 44450095)
48. Langan SM, Collins P. Randomized, double-bind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2,5% and prilocaine 2,5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 2006 154 : 146 149. (Pubitemid 43381334)
49. Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic thrapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment: a pilot study. Dermatol Surg 2004 30 : 63 66. (Pubitemid 38174032)
50. de Haas ER, de Vijlder HC, Sterenborg HJ, Neumann HA, Robinson DJ. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2008 22 : 426 430.
51. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photoderatol Photoimmunol Photomed 2003 19 : 134 141. (Pubitemid 36889801)
52. th annual congress. 2009 Abstract book : 48.
53. Christensen E, Skogvoll E, Viset T, Warloe T, Sundsrøm S. DMSO supported PDT and curettage in BCC - a 6 year clinical and histological follow up. J Eur Acad Dermatol Venereol 2009 23 : 58 66.
54. Cox NH, Eady DJ, Morton CA. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol 2007 156 : 11 21. (Pubitemid 44924139)
55. Calzavara-Pinton PG, Venturini M, Sala R et al. Methylaminolaevulinate- based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J Dermatol 2008 159 : 137 144. (Pubitemid 351874478)
56. Rhodes LE, de Rie MA, Leifsdottir R et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007 143 : 1131 1136. (Pubitemid 47443364)
57. Stasko T, Brown MD, Carucci JA et al., International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004 30 (4 Pt 2 642 650. (Pubitemid 38525895)